NCT07263399

Brief Summary

The goal of this trial is to investigate whether adding a small fraction of hydrogen gas to an oxygen-enriched breathing mixture can reduce pulmonary oxygen toxicity (POT) in healthy and active divers from the Swedish Armed Forces. The main questions it aims to answer are:

  • Does hydrogen gas reduce oxidative stress and changes in pulmonary function associated with prolonged hyperbaric oxygen exposure?
  • What are the underlying pathophysiological mechanisms of pulmonary oxygen toxicity? Researchers will compare oxygen-enriched breathing gas with 1-2% hydrogen to oxygen-enriched gas with 1-2% nitrogen (control) to see if hydrogen provides protective effects against POT during hyperbaric exposure. Participants will:
  • Complete two hyperbaric exposure sessions (hydrogen vs. nitrogen), each lasting 240 minutes at 1.75 ATA
  • Undergo pulmonary function tests and sampling of blod and urin before and after each session
  • Serve as their own controls in a double-blind, randomized, crossover study design

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
56mo left

Started Jan 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jan 2026Dec 2030

First Submitted

Initial submission to the registry

September 29, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 4, 2025

Completed
28 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

December 4, 2025

Status Verified

December 1, 2025

Enrollment Period

3.9 years

First QC Date

September 29, 2025

Last Update Submit

December 1, 2025

Conditions

Keywords

Pulmonary Oxygen ToxicityHydrogen GasDiving PhysiologyLung FunctionHyperbaric OxygenHuman StudyMilitary Divers

Outcome Measures

Primary Outcomes (1)

  • Change in Vital Capacity (ΔVC)

    Absolute change in vital capacity (VC), calculated as the difference in liters (L) between pre-exposure and post-exposure spirometry values, measured after each hyperbaric oxygen exposure session.

    Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.

Secondary Outcomes (15)

  • Forced Expiratory Volume in One Second (FEV₁)

    Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure

  • Change in FEV₁/FVC ratio

    Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure

  • Change in Forced Expiratory Flow 25-75% (FEF25-75%)

    Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.

  • Change in Peak Expiratory Flow (PEF)

    Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.

  • Change in Inspiratory Capacity (IC)

    Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.

  • +10 more secondary outcomes

Other Outcomes (1)

  • Anthropometric Measurements (Weight, Height, Sex, Age, BMI)

    Baseline (Pre-exposure, prior to first dive session)

Study Arms (2)

Hydrogen Gas Intervention

EXPERIMENTAL

In this arm, participants will undergo a single hyperbaric exposure breathing a gas mixture composed of 98-99% oxygen and 1-2% hydrogen (H₂) at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate whether hydrogen gas has protective effects against pulmonary oxygen toxicity. Pulmonary function tests and blood and urin sampling for oxidative stress biomarkers will be performed both before and after the exposure session. The order of intervention and control exposures is randomized and the study is conducted in a double-blind fashion. A washout period of at least two weeks will follow before the control

Other: Inhaled Hydrogen-Enriched Oxygen GasOther: Inhaled Nitrogen-Enriched Oxygen Gas

Nitrogen Gas Control

ACTIVE COMPARATOR

In this arm, participants will undergo a single hyperbaric exposure breathing a gas mixture composed of 98-99% oxygen and 1-2% nitrogen (N₂) at a partial pressure of 1.75 ATA for 240 minutes. This exposure serves as the control condition and represents the standard oxygen-enriched breathing gas currently in use. Pulmonary function tests and blood and urin sampling for oxidative stress biomarkers will be performed both before and after the exposure session. Participants will be randomized to the order of exposures, and both participants and investigators will be blinded to the gas composition. A washout period of at least two weeks will follow before the intervention.

Other: Inhaled Hydrogen-Enriched Oxygen GasOther: Inhaled Nitrogen-Enriched Oxygen Gas

Interventions

Participants will inhale a gas mixture consisting of 98-99% oxygen and 1-2% hydrogen via a breathing circuit during a single hyperbaric exposure. The exposure will be conducted at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate the protective effect of hydrogen gas against pulmonary oxygen toxicity.

Hydrogen Gas InterventionNitrogen Gas Control

Participants will inhale a gas mixture consisting of 98-99% oxygen and 1-2% nitrogen via a breathing circuit during a single hyperbaric exposure. The exposure will be conducted at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate the protective effect of hydrogen gas against pulmonary oxygen toxicity.

Hydrogen Gas InterventionNitrogen Gas Control

Eligibility Criteria

Age20 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Military divers actively serving, aged 20-64 years
  • Meeting the Swedish Armed Forces physical standards for diving

You may not qualify if:

  • Ongoing infection or illness that may impact pulmonary function
  • Use of alcohol or smoking cigarettes within 48 hours
  • Diving with any breathing gas within 48 hours
  • Diving with oxygen-enriched gas (100% O₂) within 2 weeks
  • Use of medications that could affect oxidative stress, lung function, or neurological status
  • Medical history of serious diving-related injuries or long-term complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Blekinge Institute of Technology

Karlskrona, Blekinge County, 37179, Sweden

Location

Swedish Armed Forces Diving and Naval Medicine Centre (DNC)

Karlskrona, Sweden

Location

Related Publications (4)

  • de Jong FJM, Wingelaar TT, van Hulst RA. Pulmonary oxygen toxicity in occupational diving. Occup Med (Lond). 2023 Jun 26;73(5):231-232. doi: 10.1093/occmed/kqad043.

  • Kawamura T, Wakabayashi N, Shigemura N, Huang CS, Masutani K, Tanaka Y, Noda K, Peng X, Takahashi T, Billiar TR, Okumura M, Toyoda Y, Kensler TW, Nakao A. Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo. Am J Physiol Lung Cell Mol Physiol. 2013 May 15;304(10):L646-56. doi: 10.1152/ajplung.00164.2012. Epub 2013 Mar 8.

  • Yildiz F, LeBaron TW, Alwazeer D. A comprehensive review of molecular hydrogen as a novel nutrition therapy in relieving oxidative stress and diseases: Mechanisms and perspectives. Biochem Biophys Rep. 2025 Jan 25;41:101933. doi: 10.1016/j.bbrep.2025.101933. eCollection 2025 Mar.

  • Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007 Jun;13(6):688-94. doi: 10.1038/nm1577. Epub 2007 May 7.

MeSH Terms

Conditions

Hyperoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: This is a human randomized, double-blind, crossover trial in which each participant undergoes two separate hyperbaric oxygen exposures: one with hydrogen-enriched breathing gas (1-2% H₂) and one with nitrogen-enriched breathing gas (1-2% N₂) as control. Before and after each exposure session, participants complete standardized pulmonary function tests and provide blood and urin samples for analysis of oxidative stress biomarkers. A washout period of at least two weeks is maintained between sessions to minimize carryover effects.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2025

First Posted

December 4, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

December 1, 2030

Last Updated

December 4, 2025

Record last verified: 2025-12

Locations